前S2基因缺失、基底核心啟動子突變/前核區突變株的定量及前S2突變蛋白質的定量用以預測接受貝樂克的慢性B 型肝炎病人發生肝癌之角色

Pharmacology, Toxicology and Pharmaceutical Science

1. Mutant Protein 100%
2. Entecavir 100%
3. Liver Cell Carcinoma 100%
4. Hepatitis B Virus 100%
5. Hepatitis B Antigen 50%
6. Enzyme-Linked Immunosorbent Assay 20%
7. Antiviral Therapy 20%
8. Chronic Hepatitis B 20%
9. Chronic Hepatitis 10%
10. Liver Fibrosis 10%
11. Hepatitis B(e) Antigen 10%
12. Host Factor 10%
13. Hepatitis 10%
14. Drug Resistance 10%
15. Virus DNA 10%

Immunology and Microbiology

1. Hepatitis B Virus 100%
2. Promoter Region 100%
3. HBsAg 50%
4. Hepatitis B Antigen 50%
5. Deletion Mutant 30%
6. Viral Load 20%
7. Pyrosequencing 20%
8. Hepatitis B 20%
9. ELISA 20%
10. Virus Mutant 10%
11. Genetic Variability 10%
12. Host Factor 10%
13. Drug Resistance 10%
14. Viral Replication 10%
15. Hepatitis B(e) Antigen 10%
16. Wild Type 10%
17. DNA Virus 5%
18. DNA Virus 5%
19. Hepatitis 5%